Literature DB >> 11516096

Molecular cytogenetic characterization and clinical relevance of additional, complex and/or variant chromosome abnormalities in acute promyelocytic leukemia.

L Xu1, W L Zhao, S M Xiong, X Y Su, M Zhao, C Wang, Y R Gao, C Niu, Q Cao, B W Gu, Y M Zhu, J Gu, J Hu, H Yan, Z X Shen, Z Chen, S J Chen.   

Abstract

Acute promyelocytic leukemia (APL) is characterized by typical morphological manifestation, t(15;17) translocation and active response to all-trans retinoic acid (ATRA) in the great majority of patients. However, a subset of APL cases may present atypical phenotypic, cytogenetic or molecular features at different stages of the disease. The biological and clinical significance of these features sometimes remains obscure. In this study, 284 APL patients were cytogenetically analyzed and precise diagnosis was performed according to the molecular cytogenetic results. Twenty-six APL patients were identified as having additional, complex and/or variant chromosomal abnormalities at diagnosis or at relapse, 16 of them being further analyzed using fluorescence in situ hybridization (FISH) or chromosome painting (CP). Interestingly, some of these chromosomal aberrations were found to be associated with atypical morphology and/or drug response, indicating a genotype-phenotype correlation. Analysis of the complex karyotype may also allow a better understanding of the levels of cellular origin of the leukemogenesis. Examination of the remission induction and survival data showed that the presence of the additional/complex chromosome abnormalities was related to the prognosis in both primarily diagnosed and relapsed patients in this series.

Entities:  

Mesh:

Year:  2001        PMID: 11516096     DOI: 10.1038/sj.leu.2402205

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  20 in total

1.  Prognostic implications of additional chromosome abnormalities among patients with de novo acute promyelocytic leukemia with t(15;17).

Authors:  Peter H Wiernik; Zhuoxin Sun; Holly Gundacker; Gordon Dewald; Marilyn L Slovak; Elisabeth Paietta; Haesook T Kim; Frederick R Appelbaum; Peter A Cassileth; Martin S Tallman
Journal:  Med Oncol       Date:  2012-05-22       Impact factor: 3.064

2.  AML1-ETO and C-KIT mutation/overexpression in t(8;21) leukemia: implication in stepwise leukemogenesis and response to Gleevec.

Authors:  Yue-Ying Wang; Guang-Biao Zhou; Tong Yin; Bing Chen; Jing-Yi Shi; Wen-Xue Liang; Xiao-Long Jin; Jian-Hua You; Guang Yang; Zhi-Xiang Shen; Jue Chen; Shu-Min Xiong; Guo-Qiang Chen; Feng Xu; Yi-Wei Liu; Zhu Chen; Sai-Juan Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-13       Impact factor: 11.205

3.  A complex translocation (3;17;15) in acute promyelocytic leukemia confirmed by fluorescence in situ hybridization.

Authors:  Yanming Wang; Junjie Ma; Xinguang Liu; Riming Liu; Lingling Xu; Li Wang; Jiannong Cen; Xiaoxia Chu
Journal:  Oncol Lett       Date:  2016-10-18       Impact factor: 2.967

4.  A rare case of microgranular acute promyelocytic leukemia associated with ider(17)(q10)t(15;17) in an old-age patient.

Authors:  Min Jin Kim; Sun Young Cho; Gayoung Lim; Hoi Soo Yoon; Hee Joo Lee; Jin-Tae Suh; Juhie Lee; Woo-In Lee; Kyung Sam Cho; Tae Sung Park
Journal:  Korean J Lab Med       Date:  2011-04

5.  Successful all-trans retinoic acid treatment of acute promyelocytic leukemia in a patient with NPM/RAR fusion.

Authors:  Kiyoshi Okazuka; Masayoshi Masuko; Yoshinobu Seki; Hitomi Hama; Noriyuki Honma; Tatsuo Furukawa; Ken Toba; Kenji Kishi; Yoshifusa Aizawa
Journal:  Int J Hematol       Date:  2007-10       Impact factor: 2.490

6.  Spontaneous regression of aleukemic leukemia cutis harboring a NPM/RARA fusion gene in an infant with cutaneous mastocytosis.

Authors:  Hirokazu Kanegane; Keiko Nomura; Akihiro Abe; Teruhiko Makino; Shin Ishizawa; Tadamichi Shimizu; Tomoki Naoe; Toshio Miyawaki
Journal:  Int J Hematol       Date:  2008-12-04       Impact factor: 2.490

7.  Arsenic trioxide in front-line therapy of acute promyelocytic leukemia (C9710): prognostic significance of FLT3 mutations and complex karyotype.

Authors:  Xavier Poiré; Barry K Moser; Robert E Gallagher; Kristina Laumann; Clara D Bloomfield; Bayard L Powell; Gregory Koval; Kabir Gulati; Nicholas Holowka; Richard A Larson; Martin S Tallman; Frederick R Appelbaum; Dorie Sher; Cheryl Willman; Elisabeth Paietta; Wendy Stock
Journal:  Leuk Lymphoma       Date:  2014-02-04

Review 8.  A new transcriptional variant and small azurophilic granules in an acute promyelocytic leukemia case with NPM1/RARA fusion gene.

Authors:  Tomoe Kikuma; Yuji Nakamachi; Yoriko Noguchi; Yoko Okazaki; Daisuke Shimomura; Kimikazu Yakushijin; Katsuya Yamamoto; Hiroshi Matsuoka; Hironobu Minami; Tomoo Itoh; Seiji Kawano
Journal:  Int J Hematol       Date:  2015-09-05       Impact factor: 2.490

9.  Early Detection of t(8;21) Chromosomal Translocations During Treatment of PML-RARA Positive Acute Promyelocytic Leukemia: A Case Study.

Authors:  Walter Kleine Neto; Mariana Serpa; Sabri Saeed Sanabani; Patricia Torres Bueno; Elvira Deolinda Rodrigues Pereira Velloso; Pedro Enrique Dorlhiac-Llacer; Israel Bendit
Journal:  Clin Med Insights Oncol       Date:  2010-12-20

10.  Co-expression of t(15;17) and t(8;21) in a Case of Acute Promyelocytic Leukemia: Review of the Literature.

Authors:  Burak Uz; Eylem Eliaçık; Ayse Işık; Salih Aksu; Yahya Büyükaşık; Ibrahim C Haznedaroğlu; Hakan Göker; Nilgün Sayınalp; Osman İ Ozcebe
Journal:  Turk J Haematol       Date:  2013-12-05       Impact factor: 1.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.